Abstract
The Louis-Jeantet Prize for Medicine, 2001, has been awarded to Iain Mattaj, the scientific director of the European Molecular Biology Laboratory in Heidelberg, Alfred Wittinghofer, a director of the Max Planck Institute for Molecular Physiology in Dortmund, and Alain Fischer, director of the clinical INSERM unit of Paediatric Immunology and Haematology at the Hopital Necker des Enfants Malades in Paris. Mattaj will use the prize money to undertake further experiments to study the role of the small GTPase Ran in nuclear assembly following mitosis. Wittinghofer will investigate the structural biology of a newly identified class of GTP-binding proteins — the septins — and Fischer will continue his work on the application of gene therapy to immune deficiencies. The Louis-Jeantet Foundation for Medicine annually awards three outstanding biomedical scientists a cumulative sum of 1.8 million Swiss francs to carry out their new research projects beyond the scope of their existing funding. In addition, each prizewinner receives a personal award of 100 000 Swiss francs. D.S.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
